Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1671284/000167128424000028/neue-20231231.htm
May 2024
May 2024
April 2024
March 2024
January 2024
January 2024
January 2024
December 2023
December 2023
November 2023
As of December 31, | |||||||||||
2023 | 2022 | ||||||||||
Consumer and Patient Metrics | |||||||||||
Value-Based Consumers served1 | 355,000 | 117,000 | |||||||||
Enablement Services Lives | 106,000 | — |
Three Months Ended | Years Ended | ||||||||||||||||||||||
($ in thousands) | December 31, | December 31, | |||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Financial Metrics | |||||||||||||||||||||||
Revenue | $ | 292,871 | $ | 227,696 | $ | 1,160,802 | $ | 751,163 | |||||||||||||||
Net Loss from Continuing Operations | $ | (62,827) | $ | (84,671) | $ | (627,742) | $ | (385,242) | |||||||||||||||
Adjusted EBITDA (non-GAAP) | $ | (10,356) | $ | (22,247) | $ | (8,480) | $ | (75,095) |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1671284/000167128424000028/neue-20231231.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Bright Health Group Inc..
Bright Health Group Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:
Rating
Learn More
The regulated legal entities are required to hold certain minimum levels of risk-based capital and surplus to meet regulatory requirements.
The New Credit Agreement contains covenants that, among other things, restrict the ability of the Company and its subsidiaries to make certain restricted payments, incur additional debt, engage in certain asset sales, mergers, acquisitions or similar transactions, create liens on assets, engage in certain transactions with affiliates, change its business or make investments.
The accounting for these arrangements involves estimation given the inherent uncertainties involved in measuring current performance due to the significant lag time for items like claims run-out.
The impact from income taxes varies from the federal statutory rate of 21.0% due to state income taxes, changes in the valuation allowance for deferred tax assets and adjustments for permanent differences.
The decrease is primarily due to the full impairment of the reacquired contract intangible asset during the third quarter of 2022; for the year ended December 31, 2022 amortization of the reacquired contract intangible asset was $9.9 million, as compared to no related expense for the year ended December 31, 2023.
The decrease is primarily due...Read more
Our restructuring costs decreased by...Read more
If the revised estimate of...Read more
We make quality incentive and...Read more
We make quality incentive and...Read more
Medical costs payable includes estimates...Read more
We used a portion of...Read more
The increase in service revenue...Read more
Depreciation and amortization consist of...Read more
We are out of compliance...Read more
As material changes in the...Read more
We determined that the decrease...Read more
The impairment of our NeueCare...Read more
•Expanding our presence in core,...Read more
Restructuring charges are comprised of...Read more
Restructuring charges are comprised of...Read more
Medical costs decreased by $1.1 billion,...Read more
Medical costs of our continuing...Read more
These increases were driven by...Read more
The 2022 premium revenue was...Read more
The decrease in operating costs...Read more
This fluctuation was primarily driven...Read more
Operating costs decreased by $4.9 million,...Read more
Medical costs incurred from these...Read more
In October 2022, we announced...Read more
Operating costs decreased by $67.3 million,...Read more
We believe our differentiated care...Read more
•Continuing to drive strong results...Read more
The increase in NeueCare’s service...Read more
Depending on the healthcare professional...Read more
Depreciation and amortization decreased by...Read more
We are seeing strong growth...Read more
•Expanding our provider partnerships, meeting...Read more
The increase is primarily driven...Read more
Due to the decline in...Read more
Depreciation and amortization decreased by...Read more
Interest expense increased $25.4 million, or...Read more
For the year ended December...Read more
ACOs participate in the ACO...Read more
In connection with Incremental Amendment...Read more
In the MA risk adjustment...Read more
We believe growth in the...Read more
The increase in Bright HealthCare’s...Read more
We see our provider enablement...Read more
For IFP, we utilize external...Read more
Service revenue primarily represents revenue...Read more
Due to the decline in...Read more
On October 2, 2023, the...Read more
On November 29, 2023, Bright...Read more
This business reflects our core...Read more
(d)Restructuring and contract termination costs...Read more
The Company contracted with hospitals,...Read more
The Company contracts with hospitals,...Read more
We believe NeueSolutions provides a...Read more
NeueCare’s bad debt expense increased...Read more
In addition, during the Extended...Read more
The increase was a result...Read more
Our NeueSolutions segment is our...Read more
•Increasing access to high-quality healthcare...Read more
The Company may borrow delayed...Read more
Bad debt expense increased by...Read more
The ACO REACH Model incentivizes...Read more
During the fourth quarter, we...Read more
•Leveraging enablement solutions as platform...Read more
For 2024, we re-evaluated the...Read more
Under such contracts, the reinsurer...Read more
Under such contracts, the reinsurer...Read more
In addition, capitated revenue increased...Read more
These include employee compensation for...Read more
We see our ability to...Read more
The completion factors analysis above...Read more
On an ongoing basis, we...Read more
Affiliated revenue decreased to $5.9 million...Read more
We recognized warrant expense of...Read more
As the carrying value of...Read more
We also recognized $42.6 million of...Read more
The goodwill impairment for the...Read more
Assuming a hypothetical 1% difference...Read more
Our provider enablement business that...Read more
Specifically, we see growth opportunities...Read more
On June 30, 2023, the...Read more
These include employee compensation for...Read more
Loans under the Commitment Increase...Read more
As a result of the...Read more
As the carrying value of...Read more
On January 3, 2022, we...Read more
Emergency medical services incurred out-of-network...Read more
Our cash and investments are...Read more
We recognized $42.6 million of intangible...Read more
For reporting units where a...Read more
Although our business has evolved...Read more
NeueSolutions also supports our NeueCare...Read more
As of December 31, 2022,...Read more
If the fair value of...Read more
On January 1, 2024, we...Read more
Concurrent with the close of...Read more
Additionally, NeueSolutions’ medical costs were...Read more
As of December 31, 2023, we...Read more
This growth is significant and...Read more
Our focus is to continue...Read more
The increase in bad debt...Read more
We saw a year over...Read more
This decrease is primarily due...Read more
Included in our discontinued operations,...Read more
NeueSolutions’ operating costs increased by...Read more
Income tax benefit was $1.4 million...Read more
During the year ended December...Read more
As of December 31, 2023,...Read more
Since our founding, we have...Read more
We may also elect to...Read more
The decrease is primarily a...Read more
Our Value-Based Care Consumers within...Read more
Through these risk-bearing clinics and...Read more
NeueSolutions’ service revenue increased by...Read more
Investment purchases also decreased by...Read more
For the year ended December 31,...Read more
In 2024, we expect to...Read more
Because not all companies use...Read more
In each reporting period, our...Read more
We assess our liquidity in...Read more
Operating costs are comprised of...Read more
Capitated revenue represents revenue under...Read more
Although the business has evolved,...Read more
This eliminated the Company’s secured...Read more
As of December 31, 2023, we...Read more
Enablement services lives represent members...Read more
Additionally, the Company is actively...Read more
NeueCare’s service revenue increased $2.1 million...Read more
Our participation in value-based care...Read more
NeueSolutions’ medical costs increased by...Read more
As of December 31, 2023, we...Read more
The Company declared no dividends...Read more
As of December 31, 2023,...Read more
We have historically funded our...Read more
Included in our discontinued operations,...Read more
As of December 31, 2023,...Read more
As part of our participation...Read more
Medical costs consist of reimbursements...Read more
•Executing on the efficient run-off...Read more
The loss from discontinued operations...Read more
As of December 31, 2023,...Read more
For the years ended December...Read more
As a result, we expect...Read more
Due to the decline in...Read more
The intention of the ACO...Read more
As of December 31, 2023, NeueSolutions...Read more
On April 28, 2023, the...Read more
Total revenue increased by $409.6 million,...Read more
Medical costs increased by $333.6 million,...Read more
NeueSolutions’ bad debt expense for...Read more
Prescription drug costs were determined...Read more
Changes to these estimates over...Read more
In certain instances, when there...Read more
Completion Factors: A completion factor...Read more
NeueCare capitated revenue increased by...Read more
It also informs our management...Read more
Value-based care consumers are consumers...Read more
The Fourth Waiver amended and...Read more
(g)Represents the change in fair...Read more
Prior to the bankruptcy filing...Read more
In developing our medical costs...Read more
NeueSolutions’ ACO REACH revenue increased...Read more
Actual results may differ from...Read more
ACO REACH revenue represents the...Read more
The year ended December 31, 2023...Read more
The increase in medical costs...Read more
As of December 31, 2023,...Read more
The increase in bad debt...Read more
NeueHealth is focused on our...Read more
We bring the people, process,...Read more
Our NeueCare segment is focused...Read more
For periods prior to the...Read more
Operating costs within discontinued operations...Read more
For value-based arrangements in which...Read more
These include patient copayments and...Read more
The Second Waiver amended the...Read more
Cash and investment balances held...Read more
On February 28, 2023, the...Read more
The Third Waiver amended the...Read more
As of December 31, 2023, we...Read more
For the Bright HealthCare reporting...Read more
If our qualitative assessment indicates...Read more
In the event the Company...Read more
We base our estimates on...Read more
Medical costs of our continuing...Read more
Plans receive higher payments for...Read more
On March 1, 2023, the...Read more
In the IFP line of...Read more
•Continued right-sizing of our administrative...Read more
If the fair value of...Read more
The majority of medical costs...Read more
The sources of investment income...Read more
In addition, for the year...Read more
We estimated the fair values...Read more
Goodwill impairment within our continuing...Read more
(f)Represents the change in the...Read more
The Third Waiver amended and...Read more
On January 2, 2024, both...Read more
This is a result of...Read more
The bad debt expense was...Read more
Income tax expense (benefit) consists...Read more
As of December 2023, NeueCare...Read more
Completion factors are the most...Read more
Reinsurance arrangements enable us to...Read more
Reinsurance arrangements enable us to...Read more
Our ACO REACH provider risk...Read more
There is additional consideration in...Read more
Value-based revenue aligns incentives between...Read more
As a result of our...Read more
Represents losses associated with the...Read more
In our ACO REACH business,...Read more
This impairment was driven by...Read more
Historically, we test goodwill for...Read more
Additionally, the loss from our...Read more
Loss from discontinued operations decreased...Read more
In response to these conditions,...Read more
On August 4, 2023, the...Read more
The increase in medical costs...Read more
Of the $380.2 million of...Read more
Plans with a plan level...Read more
Additionally, this measure is not...Read more
December 31, 2023, as compared to...Read more
Goodwill impairment within our discontinued...Read more
To estimate the fair value...Read more
To estimate the fair value...Read more
Such revenue includes capitation payments,...Read more
Our operating cost ratio of...Read more
These costs can vary from...Read more
(b)Transaction costs include accounting, tax,...Read more
For the year ended December 31,...Read more
For the year ended December 31,...Read more
The risk adjustment programs in...Read more
The sources of investment income...Read more
(e)Represents the costs expected to...Read more
The New Credit Agreement constitutes...Read more
Our value-driven care delivery business...Read more
On June 29, 2023, the...Read more
NeueCare aims to significantly reduce...Read more
In 2023, premium revenue for...Read more
Our model is differentiated, and...Read more
When testing goodwill for impairment,...Read more
Our expected primary uses on...Read more
If the revised estimate of...Read more
For the most recent two...Read more
This decrease was driven by...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Bright Health Group Inc. provided additional information to their SEC Filing as exhibits
Ticker: BHG
CIK: 1671284
Form Type: 10-K Annual Report
Accession Number: 0001671284-24-000028
Submitted to the SEC: Thu Mar 28 2024 5:18:37 PM EST
Accepted by the SEC: Thu Mar 28 2024
Period: Sunday, December 31, 2023
Industry: Hospital And Medical Service Plans